List of works - Nathalie Auphan-Anezin

Activated STAT5 promotes long-lived cytotoxic CD8+ T cells that induce regression of autochthonous melanoma

scientific article published on 07 November 2011

Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling

scientific article published on 4 September 2013

Control of CD8 T cell proliferation and terminal differentiation by active STAT5 and CDKN2A/CDKN2B.

scientific article published on 15 June 2015

Disrupted lymph node and splenic stroma in mice with induced inflammatory melanomas is associated with impaired recruitment of T and dendritic cells.

scientific article

Distinct orientation of the alloreactive monoclonal CD8 T cell activation program by three different peptide/MHC complexes

scholarly article by Nathalie Auphan-Anezin et al published July 2006 in European Journal of Immunology

Distinct patterns of cytolytic T-cell activation by different tumour cells revealed by Ca2+ signalling and granule mobilization

scientific article published on 07 October 2016

Expression of POU2F3 Transcription Factor Control Inflammation, Immunological Recruitment and Metastasis of Pancreatic Cancer in Mice

scientific article published on 19 October 2020

How much can a T-cell antigen receptor adapt to structurally distinct antigenic peptides?

scientific article

IFNγ producing CD8(+) T cells modified to resist major immune checkpoints induce regression of MHC class I-deficient melanomas

scientific article published on February 2015

Immunosuppression in inflammatory melanoma: can it be resisted by adoptively transferred T cells?

scientific article published on 27 December 2012

In the absence of its cytosolic domain, the CD28 molecule still contributes to T cell activation.

scientific article published on March 2015

Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression

scientific article published on 28 March 2019

Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion.

scientific article

Polymerase III transcription is necessary for T cell priming by dendritic cells

scientific article published on 21 October 2019

Silence STAT3 in the procancer niche… and activate CD8+ T cells to kill premetastatic myeloid intruders

scientific article published on January 2015

Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression

scientific article published on 02 August 2019

Temporal cross-talk between TCR and STAT signals for CD8 T cell effector differentiation.

scientific article published on December 2006

The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells

scientific article

List of works by Nathalie Auphan-Anezin

Activated STAT5 promotes long-lived cytotoxic CD8+ T cells that induce regression of autochthonous melanoma

Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling

Control of CD8 T cell proliferation and terminal differentiation by active STAT5 and CDKN2A/CDKN2B.

Disrupted lymph node and splenic stroma in mice with induced inflammatory melanomas is associated with impaired recruitment of T and dendritic cells.

Distinct orientation of the alloreactive monoclonal CD8 T cell activation program by three different peptide/MHC complexes

Distinct patterns of cytolytic T-cell activation by different tumour cells revealed by Ca2+ signalling and granule mobilization

Expression of POU2F3 Transcription Factor Control Inflammation, Immunological Recruitment and Metastasis of Pancreatic Cancer in Mice

How much can a T-cell antigen receptor adapt to structurally distinct antigenic peptides?

IFNγ producing CD8(+) T cells modified to resist major immune checkpoints induce regression of MHC class I-deficient melanomas

Immunosuppression in inflammatory melanoma: can it be resisted by adoptively transferred T cells?

In the absence of its cytosolic domain, the CD28 molecule still contributes to T cell activation.

Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression

Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion.

Polymerase III transcription is necessary for T cell priming by dendritic cells

Silence STAT3 in the procancer niche… and activate CD8+ T cells to kill premetastatic myeloid intruders

Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression

Temporal cross-talk between TCR and STAT signals for CD8 T cell effector differentiation.

The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells